Thyroid cancer cases are rising across the globe—but why? Is it simply better detection, or are lifestyle and environmental factors silently driving this surge? Could obesity, radiation, or even everyday chemicals be putting millions at risk?
Thyroid cancer, affecting the small butterfly-shaped gland at the base of the neck, is increasing faster than most other cancers in many countries. The thyroid regulates metabolism, heart rate, body temperature, and weight. Cancer develops when its cells grow uncontrollably, forming tumors that can sometimes spread to nearby tissues or other organs. While most cases are treatable, the rapid rise in diagnoses has experts concerned.
In the United States, SEER data shows that between 1980 and 2016, thyroid cancer cases more than tripled—from 2.39 to 7.54 per 100,000 men, and 6.15 to 21.28 per 100,000 women. “Thyroid cancer is one of the few cancers still on the rise despite medical advances,” says Sanziana Roman, endocrine surgeon at UCSF.
Radiation exposure in childhood is a known risk factor. Events like the Chernobyl disaster caused spikes in children, and atomic-bomb survivors in Japan showed similar trends. Yet in countries like the US, without such nuclear exposure, the rise puzzled experts.
Part of the explanation lies in improved detection. The introduction of thyroid ultrasonography in the 1980s and fine-needle biopsies in the 1990s allowed doctors to identify very small tumors that previously went unnoticed. “We can now detect tiny papillary cancers that are often slow-growing and harmless,” explains epidemiologist Cari Kitahara. Overdiagnosis is evident in countries like South Korea, where thyroid cancer rates soared after nationwide screening programs and dropped when the programs were reduced.
Detection alone, however, does not explain the full picture. Middle-income countries without extensive screening are also seeing increases, and larger, more aggressive tumors are being diagnosed more frequently. Obesity has emerged as a key factor, with high BMI linked to both higher risk and more aggressive disease. Hormonal imbalances, especially elevated thyroid-stimulating hormone (TSH), may further contribute.
Environmental exposures are also under investigation. Endocrine-disrupting chemicals in household products, trace elements in volcanic regions, and medical radiation from CT scans may all play a role. “It’s likely a multifactorial phenomenon,” says Roman. “Lifestyle, environmental, dietary, hormonal, and genetic factors interact to influence thyroid cancer risk.”
Treatment has improved, with partial thyroid removal and targeted radioactive iodine use now common, reducing unnecessary complications. Yet the rising incidence raises urgent questions. Thyroid cancer is usually treatable, but understanding why it is increasing globally is crucial. Are we seeing a hidden epidemic, or is modern medicine simply uncovering a problem that has always existed?
